MYGN · Categories · Form 4

MYGN - SEC Form 4 insider transactions

Myriad Genetics Inc. (MYGN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for MYGN

• 14d
  SEC Form 4 filed by Verratti Mark

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 14d
  SEC Form 4 filed by Muzzey Dale

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 37d
  SEC Form 4 filed by Verratti Mark

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 37d
  SEC Form 4 filed by Muzzey Dale

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 37d
  SEC Form 4 filed by Wheeler Benjamin Richard

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 44d
  Chief Technology Officer Haas Kevin Richard covered exercise/tax liability with 22,310 shares, decreasing direct ownership by 11% to 180,022 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 44d
  Chief Scientific Officer Muzzey Dale was granted 173,196 shares and covered exercise/tax liability with 37,799 shares, increasing direct ownership by 70% to 329,275 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 44d
  Chief People Officer Solaiman Shereen was granted 173,196 shares and covered exercise/tax liability with 14,683 shares, increasing direct ownership by 145% to 267,801 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 44d
  Chief Legal Officer Fox Jennifer Lynne was granted 195,876 shares and covered exercise/tax liability with 5,995 shares, increasing direct ownership by 158% to 310,362 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 44d
  Chief Operating Officer Verratti Mark was granted 247,423 shares and covered exercise/tax liability with 29,289 shares, increasing direct ownership by 53% to 632,770 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 44d
  Chief Commerical Officer Donnelly Brian J was granted 226,804 shares, increasing direct ownership by 57% to 624,338 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 44d
  Chief Financial Officer Wheeler Benjamin Richard was granted 206,186 shares and covered exercise/tax liability with 4,752 shares, increasing direct ownership by 206% to 299,058 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 44d
  President and CEO Raha Samraat S. covered exercise/tax liability with 47,120 shares and was granted 618,557 shares, increasing direct ownership by 116% to 1,064,541 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 58d
  Chief People Officer Solaiman Shereen covered exercise/tax liability with 1,675 shares, decreasing direct ownership by 2% to 109,288 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 85d
  Chief Operating Officer Verratti Mark was granted 32,810 shares, increasing direct ownership by 9% to 414,636 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 85d
  Chief Financial Officer Wheeler Benjamin Richard was granted 4,994 shares, increasing direct ownership by 5% to 97,624 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 85d
  Chief Technology Officer Haas Kevin Richard was granted 23,697 shares, increasing direct ownership by 13% to 202,332 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 85d
  Chief Scientific Officer Muzzey Dale was granted 23,697 shares, increasing direct ownership by 14% to 193,878 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 117d
  Chief Scientific Officer Muzzey Dale covered exercise/tax liability with 418 shares, decreasing direct ownership by 0.25% to 170,181 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 121d
  Chief Financial Officer Wheeler Benjamin Richard covered exercise/tax liability with 21 shares, decreasing direct ownership by 0.02% to 92,630 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 138d
  President and CEO Raha Samraat S. covered exercise/tax liability with 29,634 shares, decreasing direct ownership by 6% to 453,104 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 176d
  SEC Form 4 filed by EVP, Strategy & Transformation Ancona Margaret

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 187d
  SEC Form 4 filed by Chief Accounting Officer Munk Natalie

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 219d
  Chief Operating Officer Verratti Mark covered exercise/tax liability with 1,085 shares, decreasing direct ownership by 0.28% to 381,826 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 219d
  Chief Accounting Officer Munk Natalie covered exercise/tax liability with 962 shares, decreasing direct ownership by 2% to 45,167 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 219d
  Chief Financial Officer Wheeler Benjamin Richard covered exercise/tax liability with 2,559 shares, decreasing direct ownership by 3% to 92,651 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 219d
  EVP, Strategy & Transformation Ancona Margaret covered exercise/tax liability with 958 shares, decreasing direct ownership by 0.74% to 127,726 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 237d
  Chief Legal Officer Fox Jennifer Lynne covered exercise/tax liability with 4,435 shares, decreasing direct ownership by 4% to 120,481 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 253d
  Chief Financial Officer Wheeler Benjamin Richard was granted 60,000 shares, increasing direct ownership by 170% to 95,210 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 254d
  SEC Form 4 filed by Chief Financial Officer Leffler Scott J.

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 327d
  Director Dreismann Heinrich was granted 49,796 shares, increasing direct ownership by 41% to 171,444 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 327d
  Director Bisaro Paul was granted 49,796 shares, increasing direct ownership by 124% to 89,941 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 327d
  Director Davis Mark Steven was granted 24,148 shares, increasing direct ownership by 106% to 46,964 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 327d
  Director Phanstiel S. Louise was granted 49,796 shares, increasing direct ownership by 39% to 177,444 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 327d
  Director Newcomer Lee Nisley was granted 49,796 shares, increasing direct ownership by 60% to 132,141 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 327d
  Director Reitan Colleen F was granted 49,796 shares, increasing direct ownership by 117% to 92,329 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 327d
  Director Kumar Rashmi was granted 49,796 shares, increasing direct ownership by 64% to 127,188 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 327d
  Director Skovronsky Daniel was granted 49,796 shares, increasing direct ownership by 58% to 135,806 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 331d
  President and CEO Raha Samraat S. was granted 1,498 shares, increasing direct ownership by 0.31% to 482,738 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 362d
  Chief Commerical Officer Donnelly Brian J was granted 397,534 shares (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 363d
  SEC Form 4 filed by Chief Operating Officer Verratti Mark

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 363d
  SEC Form 4 filed by President and CEO Raha Samraat S.

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 364d
  SEC Form 4 filed by President and CEO Diaz Paul J

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 379d
  Chief Scientific Officer Muzzey Dale covered exercise/tax liability with 942 shares, decreasing direct ownership by 0.55% to 170,599 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 379d
  Chief Commercial Officer Verratti Mark covered exercise/tax liability with 1,085 shares, decreasing direct ownership by 0.28% to 382,911 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 399d
  Chief Accounting Officer Munk Natalie covered exercise/tax liability with 362 shares, decreasing direct ownership by 0.78% to 46,129 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 400d
  SVP, Chief of Staff Ancona Margaret covered exercise/tax liability with 2,622 shares, decreasing direct ownership by 2% to 128,684 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 400d
  Chief Accounting Officer Munk Natalie covered exercise/tax liability with 2,545 shares, decreasing direct ownership by 5% to 46,491 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 400d
  Chief Technology Officer Haas Kevin Richard covered exercise/tax liability with 9,088 shares, decreasing direct ownership by 5% to 178,635 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 400d
  Chief Scientific Officer Muzzey Dale covered exercise/tax liability with 8,690 shares, decreasing direct ownership by 5% to 171,541 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 400d
  Chief Commercial Officer Verratti Mark covered exercise/tax liability with 7,690 shares, decreasing direct ownership by 2% to 383,996 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 400d
  President and CEO Diaz Paul J covered exercise/tax liability with 117,680 shares, decreasing direct ownership by 12% to 891,844 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 408d
  Chief Accounting Officer Munk Natalie was granted 4,000 shares and covered exercise/tax liability with 1,539 shares, increasing direct ownership by 5% to 49,036 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 408d
  SVP, Chief of Staff Ancona Margaret was granted 54,124 shares and covered exercise/tax liability with 4,989 shares, increasing direct ownership by 60% to 131,306 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 408d
  Chief Technology Officer Haas Kevin Richard was granted 54,124 shares and covered exercise/tax liability with 7,725 shares, increasing direct ownership by 33% to 187,723 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 408d
  Chief People Officer Solaiman Shereen was granted 63,145 shares and covered exercise/tax liability with 6,060 shares, increasing direct ownership by 106% to 110,963 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 408d
  Chief Scientific Officer Muzzey Dale was granted 75,773 shares and covered exercise/tax liability with 13,308 shares, increasing direct ownership by 53% to 180,231 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 408d
  President and CEO Diaz Paul J covered exercise/tax liability with 67,682 shares, decreasing direct ownership by 6% to 1,009,524 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 408d
  Chief Legal Officer Fox Jennifer Lynne was granted 63,145 shares, increasing direct ownership by 102% to 124,916 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)
• 408d
  Chief Financial Officer Leffler Scott J. was granted 72,165 shares and covered exercise/tax liability with 6,217 shares, increasing direct ownership by 43% to 218,393 units (SEC Form 4)

  4 - MYRIAD GENETICS INC (0000899923) (Issuer)

Other MYGN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends